Safety and efficacy of a combination therapy with Revlimid, Adriamycin and dexamethasone (RAD) in relapsed/refractory multiple myeloma (MM): a single-centre experience.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples